Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1674954

Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma

Provisionally accepted
Zhongqing ZouZhongqing Zou1Sihan LaiSihan Lai2Hai YiHai Yi2Qian ZhangQian Zhang2Hao YaoHao Yao1Hui YangHui Yang2Ling ZhangLing Zhang1ALEX H CHANGALEX H CHANG3,4*Yi SuYi Su2*Jin RaoJin Rao1*
  • 1Department of Hematology, Affiliated Hospital and Clinical Medical College of Chengdu University, Chengdu, China
  • 2Department of Hematology, Chinese People's Liberation Army Western Theater General Hospital, Chengdu, China
  • 3Shanghai Yake Biotechnology Ltd, Shanghai, China
  • 4Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China

This article is a correction to:

  1. Case Report: CAR-T Therapy for Primary Cerebellar ALK-Negative Anaplastic Large Cell Lymphoma

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. Frontiers Media SA 2 Incorrect file published File [Table 1] was erroneously published with the original version of this paper. The file has now been [removed].The original version of this article has been updated.

Keywords: Primary central nervous system lymphoma (PCNSL), T-cell lymphoma, Cerebellar, ALK, ALCL, car-t, CD30, CD7

Received: 28 Jul 2025; Accepted: 14 Aug 2025.

Copyright: © 2025 Zou, Lai, Yi, Zhang, Yao, Yang, Zhang, CHANG, Su and Rao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
ALEX H CHANG, Shanghai Yake Biotechnology Ltd, Shanghai, China
Yi Su, Department of Hematology, Chinese People's Liberation Army Western Theater General Hospital, Chengdu, China
Jin Rao, Department of Hematology, Affiliated Hospital and Clinical Medical College of Chengdu University, Chengdu, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material